Laura Sepp-Lorenzino

Companies

• Lexeo Therapeutics, Inc.Board member Apr 30, 2026 to now¹
• Taysha Gene Therapies, Inc.Board member Nov 24, 2020 to now²
• Intellia TherapeuticsEVP, Chief Scientific Officer May 29, 2019 to Jan 7, 2025³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Intellia Therapeutics NTLA77,388 shares⁴$888.4K at $11.48Jan 3, 2025
• TGTaysha Gene Therapies, Inc. TSHA127,178 shares⁵$503.0K at $3.96Jun 1, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Jun 1, 2026Granted 21,335 shares of Taysha Gene Therapies, Inc.⁵
• Jun 2, 2025Granted 56,623 shares of Taysha Gene Therapies, Inc.⁶
• Jan 3, 2025Sold 8,966 shares at $12.18 of Intellia Therapeutics⁴
• Jan 1, 2025Exercised options 3,500 shares of Intellia Therapeutics⁷
• May 29, 2024Granted 49,220 shares of Taysha Gene Therapies, Inc.⁸
• Mar 1, 2024Granted 37,966 shares of Intellia Therapeutics⁹
• Jan 8, 2024Sold 667 shares at $29.38 of Intellia Therapeutics¹⁰
• Jan 8, 2024Sold 1,608 shares at $28.66 of Intellia Therapeutics¹⁰
• Jan 3, 2024Sold 5,532 shares at $29.46 of Intellia Therapeutics¹¹
• Jan 1, 2024Exercised options 3,500 shares of Intellia Therapeutics¹²
• Mar 1, 2023Granted 29,938 shares of Intellia Therapeutics¹³
• Jan 5, 2023Sold 689 shares at $39.10 of Intellia Therapeutics¹⁴
• Jan 5, 2023Sold 1,641 shares at $38.22 of Intellia Therapeutics¹⁴
• Jan 4, 2023Sold 2,508 shares at $37.21 of Intellia Therapeutics¹⁴
• Jan 1, 2023Exercised options 3,500 shares of Intellia Therapeutics¹⁵
• Mar 1, 2022Granted 13,816 shares of Intellia Therapeutics¹⁶
• Jan 1, 2022Sold 1,148 shares at $112.25 of Intellia Therapeutics¹⁶
• Jan 1, 2022Exercised options 3,500 shares of Intellia Therapeutics¹⁶